The long QT syndrome

Europace. 2001 Jan;3(1):16-27. doi: 10.1053/eupc.2000.0141.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Cardiac Pacing, Artificial
  • Cation Transport Proteins*
  • DNA-Binding Proteins*
  • Diagnosis, Differential
  • ERG1 Potassium Channel
  • Electric Countershock
  • Electrocardiography
  • Ether-A-Go-Go Potassium Channels
  • Genetic Predisposition to Disease
  • Heart Rate
  • Humans
  • Long QT Syndrome* / diagnosis
  • Long QT Syndrome* / genetics
  • Long QT Syndrome* / physiopathology
  • Long QT Syndrome* / therapy
  • Molecular Biology / methods
  • Potassium Channels / genetics
  • Potassium Channels, Voltage-Gated*
  • Sympathectomy
  • Sympathetic Nervous System / physiopathology
  • Trans-Activators*
  • Transcriptional Regulator ERG

Substances

  • Adrenergic beta-Antagonists
  • Cation Transport Proteins
  • DNA-Binding Proteins
  • ERG protein, human
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • KCNH6 protein, human
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Trans-Activators
  • Transcriptional Regulator ERG